OPPM

Opus Point Partners Management Portfolio holdings

AUM $46.9M
1-Year Return 4.17%
This Quarter Return
-15.81%
1 Year Return
-4.17%
3 Year Return
+83.22%
5 Year Return
+175.29%
10 Year Return
–
AUM
$107M
AUM Growth
-$42.4M
Cap. Flow
-$11.9M
Cap. Flow %
-11.13%
Top 10 Hldgs %
40.3%
Holding
64
New
7
Increased
16
Reduced
26
Closed
10

Top Buys

1
PFE icon
Pfizer
PFE
$3.26M
2
BIB icon
ProShares Ultra NASDAQ Biotechnology
BIB
$2.03M
3
ALNY icon
Alnylam Pharmaceuticals
ALNY
$1.72M
4
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
$930K
5
SNR
NEW SENIOR INVESTMENT GROUP INC.
SNR
$927K

Top Sells

1
IBB icon
iShares Biotechnology ETF
IBB
$10.7M
2
GILD icon
Gilead Sciences
GILD
$2.79M
3
NSTG
NanoString Technologies, Inc.
NSTG
$1.5M
4
XNCR icon
Xencor
XNCR
$1.32M
5
AMGN icon
Amgen
AMGN
$1.29M

Sector Composition

1 Healthcare 84.87%
2 Real Estate 0.86%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
VCEL icon
26
Vericel Corp
VCEL
$1.71B
$1.75M 1.35%
298,941
-33,216
-10% -$195K
CLVS
27
DELISTED
Clovis Oncology, Inc.
CLVS
$1.44M 1.11%
75,000
+25,000
+50% +$480K
HOLX icon
28
Hologic
HOLX
$14.7B
$1.34M 1.03%
38,700
-9,300
-19% -$321K
MDCO
29
DELISTED
Medicines Co
MDCO
$1.29M 1%
40,500
+15,500
+62% +$493K
LOXO
30
DELISTED
Loxo Oncology, Inc
LOXO
$984K 0.76%
36,000
-24,000
-40% -$656K
ONCE
31
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$930K 0.72%
+31,500
New +$930K
SNR
32
DELISTED
NEW SENIOR INVESTMENT GROUP INC.
SNR
$927K 0.72%
+90,000
New +$927K
RARE icon
33
Ultragenyx Pharmaceutical
RARE
$3.01B
$855K 0.66%
+13,500
New +$855K
SDS icon
34
ProShares UltraShort S&P500
SDS
$442M
$853K 0.66%
+2,250
New +$853K
ADMS
35
DELISTED
Adamas Pharmaceuticals, Inc.
ADMS
$781K 0.6%
54,000
-26,000
-33% -$376K
ACHN
36
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
$764K 0.59%
99,000
-1,000
-1% -$7.72K
AVDL
37
Avadel Pharmaceuticals
AVDL
$1.43B
$763K 0.59%
69,109
+12,321
+22% +$136K
MACK
38
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$753K 0.58%
11,439
-4,131
-27% -$272K
PRTK
39
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$683K 0.53%
45,000
-15,000
-25% -$228K
MCRB icon
40
Seres Therapeutics
MCRB
$163M
$645K 0.5%
1,215
-435
-26% -$231K
ZGNX
41
DELISTED
Zogenix, Inc.
ZGNX
$630K 0.49%
68,130
-27,570
-29% -$255K
DRNA
42
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$579K 0.45%
108,000
+8,000
+8% +$42.9K
RXDX
43
DELISTED
Ignyta, Inc.
RXDX
$548K 0.42%
81,000
-19,000
-19% -$129K
ISEE
44
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$533K 0.41%
12,600
-4,400
-26% -$186K
EYPT icon
45
EyePoint Pharmaceuticals
EYPT
$795M
$482K 0.37%
+18,000
New +$482K
KPTI icon
46
Karyopharm Therapeutics
KPTI
$59.7M
$442K 0.34%
3,300
-700
-18% -$93.8K
UTHR icon
47
United Therapeutics
UTHR
$17.2B
$429K 0.33%
3,848
-2,666
-41% -$297K
LAB icon
48
Standard BioTools
LAB
$481M
$363K 0.28%
45,000
-25,000
-36% -$202K
LABU icon
49
Direxion Daily S&P Biotech Bull 3X Shares
LABU
$706M
$329K 0.25%
+599
New +$329K
SIOX
50
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$303K 0.23%
3,302
+945
+40% +$86.7K
1
2
3